Clinical Trial Update: Abatacept in Immune Checkpoint Inhibitor Myocarditis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating abatacept for immune checkpoint inhibitor–associated myocarditis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Myocarditis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Myocarditis Acute, Cancer | Phase 3 | Status: RECRUITING